These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1086 related items for PubMed ID: 15317270

  • 1. A randomized, controlled study of specific immunotherapy in monosensitized subjects with seasonal rhinitis: effect on bronchial hyperresponsiveness, sputum inflammatory markers and development of asthma symptoms.
    Crimi N, Li Gotti F, Mangano G, Paolino G, Mastruzzo C, Vancheri C, Lisitano N, Polosa R.
    Ann Ital Med Int; 2004; 19(2):98-108. PubMed ID: 15317270
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial.
    Walker SM, Pajno GB, Lima MT, Wilson DR, Durham SR.
    J Allergy Clin Immunol; 2001 Jan; 107(1):87-93. PubMed ID: 11149996
    [Abstract] [Full Text] [Related]

  • 5. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma.
    Roberts G, Hurley C, Turcanu V, Lack G.
    J Allergy Clin Immunol; 2006 Feb; 117(2):263-8. PubMed ID: 16461125
    [Abstract] [Full Text] [Related]

  • 6. Effect of nasal triamcinolone acetonide on seasonal variations of bronchial hyperresponsiveness and bronchial inflammation in nonasthmatic children with seasonal allergic rhinitis.
    Orhan F, Sekerel BE, Adalioglu G, Pinar M, Tuncer A.
    Ann Allergy Asthma Immunol; 2004 Apr; 92(4):438-45. PubMed ID: 15104196
    [Abstract] [Full Text] [Related]

  • 7. The type of sensitizing allergen can affect the evolution of respiratory allergy.
    Marogna M, Massolo A, Berra D, Zanon P, Chiodini E, Canonica GW, Passalacqua G.
    Allergy; 2006 Oct; 61(10):1209-15. PubMed ID: 16942571
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Sublingual immunotherapy abrogates seasonal bronchial hyperresponsiveness in children with Parietaria-induced respiratory allergy: a randomized controlled trial.
    Pajno GB, Passalacqua G, Vita D, Caminiti L, Parmiani S, Barberio G.
    Allergy; 2004 Aug; 59(8):883-7. PubMed ID: 15230823
    [Abstract] [Full Text] [Related]

  • 10. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.
    Kopp MV, Hamelmann E, Zielen S, Kamin W, Bergmann KC, Sieder C, Stenglein S, Seyfried S, Wahn U, DUAL study group.
    Clin Exp Allergy; 2009 Feb; 39(2):271-9. PubMed ID: 19016798
    [Abstract] [Full Text] [Related]

  • 11. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O, Tuncer A, Adalioglu G, Sekerel BE, Saçkesen C, Kalayci O.
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [Abstract] [Full Text] [Related]

  • 12. Rush sublingual immunotherapy in Parietaria allergic patients.
    D'Ambrosio FP, Ricciardi L, Isola S, Savi E, Parmiani S, Puccinelli P, Musarra A.
    Allergol Immunopathol (Madr); 1996 Sep; 24(4):146-51. PubMed ID: 8939269
    [Abstract] [Full Text] [Related]

  • 13. [Effect of 1-year specific immunotherapy with standardized house dust mite vaccine on mild to moderate allergic asthmatic patients].
    Wang HY, Lin XP, Hao CL, Zhang CQ, Sun BQ, Zheng JP, Chen P, Sheng JY, Wu A, Zhong NS.
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Oct; 29(10):679-87. PubMed ID: 17129496
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of the antiinflammatory and clinical effects of sublingual immunotherapy with carbamylated allergoid in allergic asthma with or without rhinitis. A 12-month perspective randomized, controlled, trial.
    La Grutta S, Arena A, D'Anneo WR, Gammeri E, Leonardi S, Trimarchi A, Platania D, La Rosa M.
    Eur Ann Allergy Clin Immunol; 2007 Feb; 39(2):40-4. PubMed ID: 17441414
    [Abstract] [Full Text] [Related]

  • 15. Changes in airway inflammation following nasal allergic challenge in patients with seasonal rhinitis.
    Bonay M, Neukirch C, Grandsaigne M, Leçon-Malas V, Ravaud P, Dehoux M, Aubier M.
    Allergy; 2006 Jan; 61(1):111-8. PubMed ID: 16364165
    [Abstract] [Full Text] [Related]

  • 16. [Preventive immunotherapy].
    Boquete M, Carballada F, Expósito F, González A.
    Allergol Immunopathol (Madr); 2000 Jan; 28(3):89-93. PubMed ID: 10867376
    [Abstract] [Full Text] [Related]

  • 17. [Bronchial reactivity in patients with seasonal allergic rhinitis].
    Gudelj I, Plavec D, Susac A, Cvitanović S, Tudorić N.
    Lijec Vjesn; 2002 Oct; 124(10):305-9. PubMed ID: 12619439
    [Abstract] [Full Text] [Related]

  • 18. Double-blind, placebo-controlled study with a modified therapeutic vaccine of Salsola kali (Russian thistle) administered through use of a cluster schedule.
    Colás C, Monzón S, Venturini M, Lezaun A.
    J Allergy Clin Immunol; 2006 Apr; 117(4):810-6. PubMed ID: 16630938
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis.
    Frew AJ, Powell RJ, Corrigan CJ, Durham SR, UK Immunotherapy Study Group.
    J Allergy Clin Immunol; 2006 Feb; 117(2):319-25. PubMed ID: 16461133
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of subcutaneous immunotherapy with a biologically standardized extract of Ambrosia artemisiifolia pollen: a double-blind, placebo-controlled study.
    Mirone C, Albert F, Tosi A, Mocchetti F, Mosca S, Giorgino M, Pecora S, Parmiani S, Ortolani C.
    Clin Exp Allergy; 2004 Sep; 34(9):1408-14. PubMed ID: 15347374
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.